Terumo Corporation (TRUMF)

Market Cap	28.68B
Revenue (ttm)	6.89B
Net Income (ttm)	834.03M
Shares Out	n/a
EPS (ttm)	0.56
PE Ratio	34.39
Forward PE	n/a
Dividend	0.15 (0.78%)
Ex-Dividend Date	Sep 27, 2024

Volume	3,400
Open	19.49
Previous Close	19.45
Day's Range	19.44 - 19.49
52-Week Range	15.00 - 22.26
Beta	0.45
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 13, 2025

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: OTCMKTS
• Ticker Symbol: TRUMF

Financial Performance

In 2023, Terumo's revenue was 921.86 billion, an increase of 12.39% compared to the previous year's 820.21 billion. Earnings were 106.37 billion, an increase of 19.09%.

Financial numbers in JPY